LC-APCI-MS-MS Analysis of Zidovudine in Human Plasma, and Application to a Bioequivalence Study

The objective of this work was to establish a sensitive, simple, accurate, and reliable LC-APCI-MS-MS method for analysis of zidovudine in human plasma. Plasma samples were processed by protein precipitation with perchloric acid solution. Separation on a 250 mm × 4.6 mm, 5 μm particle, C₁₈ column wa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chromatographia 2010-07, Vol.72 (1-2), p.151-155
Hauptverfasser: Yu, Peng, Gu, Zhenkun, Guo, Xin, Ran, Liling, Cheng, Hang, Zhang, Xingyan, Cheng, Zeneng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The objective of this work was to establish a sensitive, simple, accurate, and reliable LC-APCI-MS-MS method for analysis of zidovudine in human plasma. Plasma samples were processed by protein precipitation with perchloric acid solution. Separation on a 250 mm × 4.6 mm, 5 μm particle, C₁₈ column was achieved by use of methanol-water 65:35 (v/v) containing 0.2% formic acid as mobile phase. Mass spectrometric quantification was performed in positive-ion multiple reaction monitoring (MRM) mode, by monitoring the m/z transitions 268.1 → 127.0 for zidovudine and m/z 248.1 → 121.0 for tinidazole (internal standard). The calibration plot was linear in the concentration range 1.638-6250 μg L⁻¹, and the lower limit of quantification (LLOQ) was 1.638 μg L⁻¹. Intra-day and inter-day precision (as RSD) for zidovudine at four quality-control levels was less than 15%, and accuracy was between 95.1 and 114.2%. The method enables simple, sensitive, and accurate analysis of zidovudine in human plasma, and was successfully used in a bioequivalence study of 48 healthy Chinese volunteers.
ISSN:0009-5893
1612-1112
DOI:10.1365/s10337-010-1638-2